-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Colorectal cancer (CRC) is a common fatal disease.
Colorectal cancer (CRC) is a common fatal disease.
Worldwide, CRC is the second most common cancer among women and the third most common cancer among men, causing more than 690,000 deaths in 2012.
One comforting phenomenon is that in recent years, everyone has generally recognized that screening is a very important measure to prevent CRC.
One comforting phenomenon is that in recent years, everyone has generally recognized that screening is a very important measure to prevent CRC.
Currently, colorectal cancer screening programs and acceptance conditions in European countries are very different.
Researchers obtained data on nearly 3.
Researchers obtained data on nearly 3.
Among them, the most effective screening method for CRC is fecal occult blood, and fecal immunochemical examination (FIT) is the most widely used.
The results showed that in countries with long-term colonoscopy and stool testing programs (such as Austria, the Czech Republic, and Germany), the incidence of CRC has dropped significantly over time, and the annual average percentage change (AAPC) of men has ranged from -2.
The results showed that in countries with long-term colonoscopy and stool testing programs (such as Austria, the Czech Republic, and Germany), the incidence of CRC has dropped significantly over time, and the annual average percentage change (AAPC) of men has ranged from -2.
At the same time, in places where high screening coverage is rapidly achieved (such as Denmark, the Netherlands, and Slovenia), age-standardized incidence initially increased, but then declined.
At the same time, in places where high screening coverage is rapidly achieved (such as Denmark, the Netherlands, and Slovenia), age-standardized incidence initially increased, but then declined.
It can be seen that the different trends in the incidence, mortality, and stage distribution of colorectal cancer in various countries are mainly caused by the different implementation levels of nodal screening.
references:
references:Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.
Leave a message here
